4,7-Dibromo-5,6-di-n-octyloxy-2,1,3-benzothiadiazole, 97%, 250mg

1-Naphthoic acid methyl ester, 99.0%, 100g

1-BOC-3-CARBOXYMETHYLINDOLE, 97.0%, 500mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carbonitrile, 98%, 1g

Ethyl 3-iodo-1H-pyrrolo[3,2-c]pyridine-2-carboxylate, 95+%, 1g

Gas-tight syringe with Luer Lock connection, 5.0 ml, 1 piece

5-Fluoropyridine-2-sulfonamide, 95%, 250mg

Sulfuric acid 30%, pure, 10 l, plastic packaging.

N-(4-Fluorobenzyl)cyclopropanamine, 1g

(9H-fluoren-9-yl)methyl ((2S,3S)-1,3-dihydroxybutan-2-yl)carbamate, 98%, 1g

CIS-1,2-CYCLOPROPANE-DICARBOXYLIC ACID MONO ETHYL ESTER, 95.0%, 1g

4-bromo-5-methyl-3-isoxazolol, 95.0%, 1g

1,4-Bis(2-benzoxazolyl)naphthalene>98.0%(HPLC)(N)25g